Plainsboro, NJ, United States of America

Ravi Erukulla


Average Co-Inventor Count = 6.9

ph-index = 2

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Ravi Erukulla

Introduction

Ravi Erukulla is an accomplished inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of drug delivery systems, holding 2 patents that showcase his innovative approach to medical technology.

Latest Patents

One of his latest patents is a Modular Targeted Liposomal Delivery System. This invention involves a liposome that includes a fusogenic liposome, a linking moiety, and a targeting moiety. The fusogenic liposome consists of a lipid bilayer that encapsulates contents. The linking moiety is electrostatically bound to the lipid bilayer, while the targeting moiety is covalently bound to the linking moiety. Additionally, the liposome may contain a stabilizing moiety that is interposed between the linking and targeting moieties, which is also covalently bound to both. Alternatively, the stabilizing and targeting moieties can be covalently bound to separate linking moieties, with the linking moieties being electrostatically bound to the lipid bilayer.

Another significant patent by Erukulla involves Peptide-Lipid Conjugates, Liposomes, and Liposomal Drug Delivery. In this invention, peptide-lipid conjugates are incorporated into liposomes to selectively destabilize them in the vicinity of target peptidase-secreting cells. This allows for the effective delivery of liposomes to the target cells or directly into the cells. The liposomes can be utilized to treat various diseases, disorders, or conditions, such as tumors, microbial infections, and inflammations, characterized by the presence of peptidase-secreting cells.

Career Highlights

Throughout his career, Ravi Erukulla has worked with notable companies, including Elan Pharmaceutical Technologies, Inc. and Transave Limited. His work in these organizations has contributed to advancements in pharmaceutical technologies and drug delivery systems.

Collaborations

Ravi has collaborated with esteemed colleagues such as Paul R. Meers and Andrew S. Janoff, further enhancing his contributions to the field.

Conclusion

Ravi Erukulla's innovative patents and career achievements highlight his significant role in advancing drug delivery systems. His work continues to impact the medical field positively, paving the way for new treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…